🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Belgium / NCT07236021
Recruiting Not applicable

e-Motion : Promoting Emotion Regulation in Chronic Cancer

NCT07236021 · tracked via the Priya Life Science Belgium tracker
Phase
Not applicable
Started
2025-11-20
Last updated
2025-11-21

Condition(s) studied

Metastatic CancersMyeloma Multiple

Investigational drug(s) / intervention(s)

Guided Self-Help interventionGroup and Guided Self-Help intervention

Guided Self-Help intervention: This intervention will consist of 8 self-administered modules that patients will complete every week. The sessions integrate an emotion regulation component with breathing exercises, relaxation exercises, hypnosis, etc. Once a week (maximum 15-minute), a trained psychologist will call the patient to help and/or encourage them. Each module will consist of podcasts, a reading assignment (with psycho-educational information) and writing assignments. The intervention will include home exercises and patients will be encouraged to practice exercises and skills learned between the sessions.

Group and Guided Self-Help intervention: It will consist of the same content described above, but given in 8 group sessions (2-hour) held by videoconference (Zoom) that will take place every week. Patients will also have access to the podcasts, home exercises and reading assignment, but will benefit from increased motivation and support from both the therapist and their peers in the group. Each group will be composed of 5 patients.

Study summary

The present study aimed to pilot evaluate two interventions: a Guided Self-Help Intervention alone, and a combined Group and Guided Self-Help Intervention, designed to support individuals living with chronic cancer and recently diagnosed. The primary aim of this pilot study is to assess the feasibility, acceptability and tolerability of the interventions. The secondary aim of the pilot study is to assess the interventions preliminary efficacy and differences on psychological symptoms.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Having received a diagnosis of chronic cancer (metastatic breast cancer, metastatic melanoma, metastatic colorectal, metastatic ovarian, metastatic uterine, metastatic endometrial, metastatic prostate, metastatic bladder, metastatic kidney or metastatic testicular cancer, symptomatic multiple myeloma, metastatic non-small cell lung, metastatic mesothelioma or metastatic thymoma) in the past 12 months, * Having completed at least one active treatment session (e.g., chemotherapy, surgery, radiotherapy, immunotherapy, target therapy). Exclusion Criteria: * Having less than one year of life expectancy * Having more than one treatment line (for triple negative breast cancer, melanoma, gynecological cancer, colorectal cancer, bladder cancer, kidney cancer, non-small cell lung, mesothelioma and thymoma) or two treatment lines (for other breast cancers and testicular cancer) or three treatment lines (for prostate cancer and multiple myeloma), * Having a diagnosis of oligometastatic cancer, * Age \< 18 years, * Non-fluency in French, * Inability to follow the online intervention, * Severe cognitive impairment, and severe and/or acute psychiatric disorder.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Institut Jules Bordet, Hôpital universitaire de Bruxelles Brussels Anderlecht Not Yet Recruiting
H.U.B Institut Jules Bordet Brussels Brussels Capital Recruiting

More Université Libre de Bruxelles trials in Belgium

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07236021 on ClinicalTrials.gov ↗ ← All trials in Belgium